The difference is more pronounced when evaluating the percentage of patients adhering to a strict glycemic control target [15]
People taking GLP-1 receptor agonists may become dehydrated from vomiting or diarrhea, causing kidney problems
[DOI] [PMC free article] [PubMed] [Google Scholar] 273.Wilding J.P.H., Batterham R.L., Davies M., Van Gaal L.F., Kandler K., Konakli K., Lingvay I., McGowan B.M., Oral T.K., Rosenstock J., et al
Studies comparing the combined therapy to individual medications found greater reductions against SGLT2is than GLP1-RAs
Abstract Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are increasingly being used to treat diabetes and obesity
IDF Diabetes Atlas 7th edn